TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30833160

Group type: EXPERIMENTAL
Intervention: Measles-rubella plus LJEV group
Number of subjects: 1093

Group type: COMPARATOR
Intervention: Measles-rubella group
Number of subjects: 1093
Study: 27807037

Group type: EXPERIMENTAL
Intervention: Calorie deprivation (266 ± 61 kcal/d)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Calorie deprivation with aerobic exercise (4 h/d at 40-65% peak VO2)
Number of subjects: 23
Study: 27228204

Group type: EXPERIMENTAL
Intervention: Nutrition-related factors including child anthropometry, breastfeeding and complementary feeding frequencies, dietary diversity, egg and oil intake, and reduced infectious disease morbidities
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Increases in length-for-age Z score
Number of subjects: 583
Study: 25480991

Group type: EXPERIMENTAL
Intervention: Next-generation zotarolimus-eluting stent (R-ZES) in bifurcation lesions
Number of subjects: 3475

Group type: EXPERIMENTAL
Intervention: Next-generation zotarolimus-eluting stent (R-ZES) in non-bifurcation lesions
Number of subjects: 3475

Group type: EXPERIMENTAL
Intervention: Next-generation zotarolimus-eluting stent (R-ZES) in bifurcation lesions (first 30 days)
Number of subjects: 3475

Group type: EXPERIMENTAL
Intervention: Next-generation zotarolimus-eluting stent (R-ZES) in non-bifurcation lesions (first 30 days)
Number of subjects: 3475

Group type: EXPERIMENTAL
Intervention: Next-generation zotarolimus-eluting stent (R-ZES) in bifurcation lesions (31 days to 3 years)
Number of subjects: 3475

Group type: EXPERIMENTAL
Intervention: Next-generation zotarolimus-eluting stent (R-ZES) in non-bifurcation lesions (31 days to 3 years)
Number of subjects: 3475
Study: 22470104

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine lozenge (NL)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo lozenge (PL)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: DT cigarette administration
Number of subjects: 27
Study: 21059743

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.25 μg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg
Number of subjects: 12
Study: 17641872

Group type: EXPERIMENTAL
Intervention: Total elbow arthroplasty using semiconstrained GSB III elbow replacement prostheses
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Total elbow arthroplasty using semiconstrained Coonrad‐Morrey prostheses
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Total elbow arthroplasty using Souter‐Strathclyde unconstrained, unlinked prosthesis
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Total elbow arthroplasty using constrained link hinge prostheses
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Total elbow arthroplasty using custom‐made prostheses
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Total elbow arthroplasty using Pritchard elbow replacement
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Total elbow replacement (all types)
Number of subjects: 177
Study: 16336366

Group type: EXPERIMENTAL
Intervention: Decision-aid booklet given at 28 weeks' gestation
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group (no decision-aid)
Number of subjects: 227
Study: 11886900

Group type: EXPERIMENTAL
Intervention: Three applications of 1000 impulses of low-energy shock waves (Group I)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Three applications of ten impulses of low-energy shock waves (Group II)
Number of subjects: 112
Study: 10634020

Group type: EXPERIMENTAL
Intervention: General anesthesia with controlled ventilation (Group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Total intravenous anesthesia (TIVA) with spontaneous breathing (Group 2)
Number of subjects: 60
Study: 10182206

Group type: EXPERIMENTAL
Intervention: Teacher characteristics and program fidelity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Teacher characteristics
Number of subjects: 0
Study: 1820294

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg b.i.d.)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 7044655

Group type: EXPERIMENTAL
Intervention: High-dose-aspirin/dipyridamole combination (990 mg/day aspirin and 225 mg/day dipyridamole)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Low-dose-aspirin/dipyridamole (330 mg/day aspirin and 225 mg/day dipyridamole)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Aspirin alone (990 mg/day)
Number of subjects: 27
Study: 31714123

Group type: EXPERIMENTAL
Intervention: Psychological resilience measures
Number of subjects: 748
Study: 29720876

Group type: EXPERIMENTAL
Intervention: Motor imagery training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (mentally stimulating games)
Number of subjects: 30
Study: 26364263

Group type: EXPERIMENTAL
Intervention: Daily combined tenofovir disoproxil fumarate (245 mg) and emtricitabine (200 mg) immediately
Number of subjects: 544
Study: 24333493

Group type: EXPERIMENTAL
Intervention: Prasugrel 10-mg once-daily maintenance dose (with or without a 60-mg loading dose)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Prasugrel (combined groups)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ticagrelor (continued therapy)
Number of subjects: 110
Study: 22315052

Group type: EXPERIMENTAL
Intervention: Novel care pathway including diagnosis of 'diseased' QoL and up to five standardised treatments for specific QoL defects
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard postoperative care adhering to the German national guideline for breast cancer
Number of subjects: 200
Study: 18571336

Group type: EXPERIMENTAL
Intervention: 3D radiation therapy (n = 29)
Number of subjects: 67

Group type: COMPARATOR
Intervention: 2D radiation therapy (n = 38)
Number of subjects: 67
Study: 17467138

Group type: EXPERIMENTAL
Intervention: Steam autoclaving (121 degrees C, 5min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Immersion in 0.1% (w/v) thymol-distilled water solution (24h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gamma irradiation (4100Gy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study: 15965572

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Device therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carvedilol or Metoprolol
Number of subjects: 0
Study: 11948036

Group type: EXPERIMENTAL
Intervention: High-intensity, lower-extremity endurance program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-intensity, multicomponent calisthenics program
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 11512042

Group type: EXPERIMENTAL
Intervention: Glucose drinks
Number of subjects: 0
Study: 9663818

Group type: EXPERIMENTAL
Intervention: Intervention group (slide show, weekly phone calls, calendar)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 45
Study: 7512292

Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 74

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 74
Study: 3042309

Group type: EXPERIMENTAL
Intervention: 40% mixed-carbohydrate diet
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 60% mixed-carbohydrate diet
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Breakfast meal (60% carbohydrate diet)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Big Mac meal (43% carbohydrate)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Breakfast meal (40% carbohydrate diet)
Number of subjects: 5
Study: 7937285

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg twice/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cyclosporine alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 10
Study: 356754

Group type: EXPERIMENTAL
Intervention: Adenine arabinoside (Vidarabine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Idoxuridine (IDU)
Number of subjects: 50
Study: 31817731

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 0
Study: 29045554

Group type: EXPERIMENTAL
Intervention: VCP (veliparib with carboplatin/paclitaxel)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: VT (veliparib with temozolomide)
Number of subjects: 290

Group type: COMPARATOR
Intervention: PCP (placebo with carboplatin/paclitaxel)
Number of subjects: 290
Study: 26578074

Group type: EXPERIMENTAL
Intervention: 3-day trimethoprim-sulfamethoxazole therapy
Number of subjects: 249

Group type: COMPARATOR
Intervention: 10-day trimethoprim-sulfamethoxazole therapy
Number of subjects: 249
Study: 24676964

Group type: EXPERIMENTAL
Intervention: C-MAP plus treatment as usual (TAU)
Number of subjects: 221

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 221
Study: 22964805

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control
Number of subjects: 160
Study: 21128814

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (15 mg twice daily for 3 weeks, followed by 20 mg once daily)
Number of subjects: 3449

Group type: COMPARATOR
Intervention: Enoxaparin plus vitamin K antagonist
Number of subjects: 3449

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (20 mg once daily)
Number of subjects: 3449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3449

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 3449
Study: 17504795

Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training (H-IMT), 3 times a week for 8 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham inspiratory muscle training (S-IMT), 3 times a week for 8 weeks
Number of subjects: 33
Study: 16321744

Group type: EXPERIMENTAL
Intervention: Perilesional fat-sparing ring observed in malignant lesions
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Perilesional fat-sparing ring observed in benign lesions
Number of subjects: 132

Group type: COMPARATOR
Intervention: Presence of fat-sparing ring related to lesion size
Number of subjects: 132

Group type: COMPARATOR
Intervention: Presence of fat-sparing ring related to lesion type
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Fat-sparing rings in metastases
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Fat-sparing rings in primary malignant tumors
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Fat-sparing rings in hemangiomas
Number of subjects: 132
Study: 11856686

Group type: EXPERIMENTAL
Intervention: Eptifibatide (loading dose via intraarterial injection or IV)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Eptifibatide (intraarterial loading dose)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (rt-PA and heparin only)
Number of subjects: 17
Study: 10192826

Group type: EXPERIMENTAL
Intervention: Guanfacine (29 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clonidine (0.5 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clonidine (2 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clonidine (5 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guanfacine (7 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 0
Study: 7478776

Group type: EXPERIMENTAL
Intervention: 10 mg aerosolized furosemide
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 2303573

Group type: EXPERIMENTAL
Intervention: 10% potassium nitrate glycerine-based gel
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: glycerine gel without potassium nitrate
Number of subjects: 12

Group type: COMPARATOR
Intervention: no gel and no treatment (control)
Number of subjects: 12
Study: 6995134

Group type: EXPERIMENTAL
Intervention: Indomethacin 15 mg t.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg t.i.d.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin 35 mg t.i.d.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-treatment periods
Number of subjects: 8
Study: 31543072

Group type: EXPERIMENTAL
Intervention: Educational animations
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Brochures with visuals
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Brochures without visuals
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Materials currently used by the NIH
Number of subjects: 1194
Study: 28490871

Group type: EXPERIMENTAL
Intervention: NPPV (Noninvasive Positive Pressure Ventilation) for 3 months
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (optimized treatment)
Number of subjects: 115
Study: 26228884

Group type: EXPERIMENTAL
Intervention: Intraventricular rtPA treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no rtPA treatment)
Number of subjects: 64
Study: 23809500

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Program for Infertility (MBPI)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 22794269

Group type: EXPERIMENTAL
Intervention: Amnesics with MTL damage including the perirhinal cortex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled interference
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amnesics with damage limited to the hippocampus
Number of subjects: 0
Study: 19440955

Group type: EXPERIMENTAL
Intervention: Nurse-administered propofol-alfentanil sedation (NAPS)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Opioid-benzodiazepine sedation (DPS)
Number of subjects: 178
Study: 19126940

Group type: EXPERIMENTAL
Intervention: Oral Sildenafil for 12 weeks
Number of subjects: 12
Study: 15679006

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 12000004

Group type: EXPERIMENTAL
Intervention: Eformoterol Turbohaler 12 microg b.i.d.
Number of subjects: 145

Group type: COMPARATOR
Intervention: Salmeterol Accuhaler 50 microg b.i.d.
Number of subjects: 145
Study: 10216323

Group type: EXPERIMENTAL
Intervention: 125 mg of intravenous methylprednisolone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Normal saline solution (placebo)
Number of subjects: 56
Study: 7793869

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil, 500 mg twice daily for 20 days
Number of subjects: 232

Group type: COMPARATOR
Intervention: Doxycycline, 100 mg three times daily for 20 days
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil
Number of subjects: 232

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 232
Study: 1699982

Group type: EXPERIMENTAL
Intervention: Amiodarone (600 mg twice daily)
Number of subjects: 8
Study: 68044

Group type: EXPERIMENTAL
Intervention: Aqueous ragweed extract (mean cumulative dose of 11.7 microng antigen E, equivalent to 4,180 PNU)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Aqueous ragweed extract (mean dose of 31.2 microng antigen E, equivalent to 11,140 PNU)
Number of subjects: 39
Study: 30523765

Group type: EXPERIMENTAL
Intervention: Selu-metinib in combination with dacarbazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dacarbazine alone
Number of subjects: 0
Study: 26970181

Group type: EXPERIMENTAL
Intervention: Low-dose moderate-intensity aerobic exercise (150 min·week(‐1))
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High-dose moderate-intensity aerobic exercise (300 min·week(‐1))
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 39
Study: 23716039

Group type: EXPERIMENTAL
Intervention: Five or more portions of FV per day for 16 weeks
Number of subjects: 83

Group type: COMPARATOR
Intervention: Two portions of FV per day for 16 weeks (Control)
Number of subjects: 83
Study: 21953877

Group type: EXPERIMENTAL
Intervention: Variable-stiffness shoes
Number of subjects: 79

Group type: COMPARATOR
Intervention: Constant-stiffness shoes
Number of subjects: 79
Study: 20184577

Group type: EXPERIMENTAL
Intervention: UK-369,003 100 mg modified release (MR)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: UK-369,003 40 mg immediate release (IR)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: UK-369,003 100 mg MR
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 17578979

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg preoperatively and 200 mg every 12 h postoperatively
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo preoperatively and matching placebo every 12 h postoperatively
Number of subjects: 200
Study: 15455468

Group type: EXPERIMENTAL
Intervention: aSAH patients
Number of subjects: 16
Study: 11890384

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine, body therapy (somatic therapy, bodywork), and guided imagery for 6 months
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard medical approaches (control group)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine, body therapy, and guided imagery
Number of subjects: 37
Study: 9567734

Group type: EXPERIMENTAL
Intervention: Stimulus control treatment and withdrawal program (medicated participants)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Stimulus control treatment (nonmedicated participants)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (medicated participants)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list control condition (nonmedicated participants)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Stimulus control treatment (medicated participants)
Number of subjects: 41
Study: 7608644

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 588

Group type: COMPARATOR
Intervention: Intra-uterine device, condom, progestogen-only pill (alternative birth-control methods)
Number of subjects: 588
Study: 2240632

Group type: EXPERIMENTAL
Intervention: Anesthesia including nitrous oxide (N2O) (50%-60%) during regional anesthesia supplemented with isoflurane and intravenous adjuvants
Number of subjects: 100

Group type: COMPARATOR
Intervention: Anesthesia excluding nitrous oxide (N2O) during regional anesthesia supplemented with isoflurane and intravenous adjuvants
Number of subjects: 100
Study: 747947

Group type: EXPERIMENTAL
Intervention: Delayed node dissection
Number of subjects: 140

Group type: COMPARATOR
Intervention: Immediate dissection
Number of subjects: 140
Study: 31677820

Group type: EXPERIMENTAL
Intervention: Carboplatin-Paclitaxel-Bevacizumab
Number of subjects: 108

Group type: COMPARATOR
Intervention: Carboplatin-Paclitaxel
Number of subjects: 108
Study: 28851171

Group type: EXPERIMENTAL
Intervention: GnRH‐a (0.1 mg subcutaneous injection)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (0.9% saline 2 ml subcutaneous injection)
Number of subjects: 40
Study: 25481036

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM17648
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23578980

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg once-daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Salbutamol nebulizer 1250 μg three times a day
Number of subjects: 29
Study: 22053981

Group type: EXPERIMENTAL
Intervention: CVR of 30:2
Number of subjects: 40

Group type: COMPARATOR
Intervention: CVR of 15:2
Number of subjects: 40
Study: 18650630

Group type: COMPARATOR
Intervention: Standard enteral nutrition (n = 53)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Immunomodulating enteral nutrition (n = 52)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Standard parenteral nutrition (n = 49)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Immunomodulating parenteral nutrition (n = 51)
Number of subjects: 205
Study: 17312651

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler with accessory device (MDI/AD)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Small Volume Nebulizer (SVN)
Number of subjects: 150
Study: 14552819

Group type: EXPERIMENTAL
Intervention: Thiopurine metabolites measurement using HPLC assay in small blood samples from fingertip.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Measurement of metabolite concentrations in whole blood versus separated RBC.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impact of 6MP dose on metabolite concentrations.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variability in metabolite concentrations.
Number of subjects: 0
Study: 10832908

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 156
Study: 9105070

Group type: EXPERIMENTAL
Intervention: Staple
Number of subjects: 72

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 72
Study: 8169485

Group type: EXPERIMENTAL
Intervention: Repair of only FDP with regional excision of FDS
Number of subjects: 33

Group type: COMPARATOR
Intervention: Repair of both FDS and FDP tendons
Number of subjects: 33
Study: 3358568

Group type: EXPERIMENTAL
Intervention: Interferon (alpha-2b, alpha-nl, beta-interferons)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 79
Study: 31828464

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 211
Study: 29546300

Group type: EXPERIMENTAL
Intervention: Maternal IDA
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Maternal NIDA
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Serum hepcidin
Number of subjects: 358
Study: 24622328

Group type: EXPERIMENTAL
Intervention: Teaching hospitals (THs)
Number of subjects: 1491

Group type: COMPARATOR
Intervention: Municipal hospitals (MHs)
Number of subjects: 1491

Group type: COMPARATOR
Intervention: Office-based physicians (OBPs)
Number of subjects: 1491
Study: 22571900

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) plus peginterferon alfa-2a (PegIFNα-2a)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Adefovir dipivoxil (ADV) alone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Peginterferon alfa-2a (PegIFNα-2a) alone
Number of subjects: 90
Study: 21062183

Group type: EXPERIMENTAL
Intervention: Core-temperature sensor ingestion at 24 hours before exercise (P1)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Core-temperature sensor ingestion at 40 minutes before exercise (P2)
Number of subjects: 7
Study: 18365136

Group type: EXPERIMENTAL
Intervention: Lateral epicondyle bandage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wrist resting splint holding the wrist in slight dorsiflexion
Number of subjects: 50